Volatile anesthetics evoke prolonged changes in the proteome of the left ventricule myocardium: Defining a molecular basis of cardioprotection?

Acta Anaesthesiologica Scandinavica

Volumn 50, Issue 4, 2006, Pages 414-427

  Kalenka, A ^a   Maurer, M H ^a   Feldmann, R E ^a   Kuschinsky, W ^a   Waschke, K F ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Desflurane; Isoflurane; Mass spectrometry; Protein expression; Proteomics; Rat; Sevoflurane; Volatile anesthetics

Indexed keywords

DESFLURANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; PROTEOME; SEVOFLURANE;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; GLYCOLYSIS; HEART LEFT VENTRICLE MUSCLE; HEART MITOCHONDRION; HEART PROTECTION; MALE; MASS SPECTROMETRY; MINIMUM LUNG ALVEOLUS CONCENTRATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STRESS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANESTHETICS, INHALATION; ANIMALS; CARDIOTONIC AGENTS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEART VENTRICLES; ISOFLURANE; MALE; MASS SPECTROMETRY; METHYL ETHERS; MYOCARDIUM; PROTEINS; RATS; RATS, WISTAR;

EID: 33645227997     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2006.00984.x     Document Type: Article

References (55)

1. Paugam-Burtz C Molliex S Lardeux B Rolland C Aubier M Desmonts JM et al. Differential effects of halothane and thiopental on surfactant protein C messenger RNA in vivo and in vitro in rats. Anesthesiology 2000 93 805 10.
2. Hamaya Y Takeda T Dohi S Nakashima S Nozawa Y. The effects of pentobarbital, isoflurane, and propofol on immediate-early gene expression in the vital organs of the rat. Anesth Analg 2000 90 1177 83.
3. Kotani N Hashimoto H Sessler DI Yasuda T Ebina T Muraoka M et al. Expression of genes for proinflammatory cytokines in alveolar macrophages during propofol and isoflurane anesthesia. Anesth Analg 1999 89 1250 6.
4. Kapinya KJ Lowl D Futterer C Maurer M Waschke KF Isaev NK et al. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 2002 7 1889 98.
5. Futterer CD Maurer MH Schmitt A Feldmann RE Kuschinsky W Waschke KF. Alterations in rat brain proteins after desflurane anesthesia. Anesthesiology 2004 100 302 8.
6. Heerdt PM The AH Markov NP. Anesthetic-induced alteration in expression of myocardial calcium cycling proteins. J Cardiothorac Vasc Anesth 2005 19 340 4.
7. Tanaka K Ludwig LM Kersten JR Pagel PS Warltier DC. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004 100 707 21.
8. Sergeev P da Silva R Lucchinetti E Zaugg K Pasch T Schaub MC et al. Trigger-dependent gene expression profiles in cardiac preconditioning: evidence for distinct genetic programs in ischemic and anesthetic preconditioning. Anesthesiology 2004 100 474 88.
9. Eger EI II Saidman LJ Brandstater B. Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology 1965 26 756 63.
10. Crawford MW Lerman J Saldivia V Carmichael FJ. Hemodynamic and organ blood flow responses to halothane and sevoflurane anesthesia during spontaneous ventilation. Anesth Analg 1992 75 1000 6.
11. Eger EI Johnson BH. MAC of I-653 in rats, including a test of the effect of body temperature and anesthetic duration. Anesth Analg 1987 66 974 6.
12. Laussmann T Janosi RA Fingas CD Schlieper GR Schlack W Schrader J et al. Myocardial proteome analysis reveals reduced NOS inhibition and enhanced glycolytic capacity in areas of low local blood flow. FASEB J 2002 16 628 30.
13. Maurer MB Berger C Wolf M Futterer CD Feldmann RE Jr. Schwab S et al. The proteome of human brain microdialysate. Proteome Sci 2003 14 7.
14. Bradford M. A rapid and sensitive method for the quantification of microgramm quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 72 248 54.
15. Choe LL Lee KH. Quantitative and qualitative measure of intralaboratory two-dimensional protein gel reproducibility and the effects of sample preparation, sample load, and image analysis. Electrophoresis 2003 24 3500 7.
16. Perkins DP Pappin DJ Creasy DM Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999 20 3551 67.
17. Dopazo J Carazo JM. Phylogenetic reconstruction using an unsupervised growing neural network that adopts the topology of a phylogenetic tree. J Mol Evol 1997 44 226 33.
18. Herrero J Valencia A Dopazo J. A hierarchical unsupervised growing neural network for clustering gene expression patterns. Bioinformatics 2001 17 126 36.
19. Anderson LS Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997 18 533 7.
20. Haynes PA Gygi SP Figeys D Aebersold R. Proteome analysis: biological assay or data archive? Electrophoresis 1998 19 1862 71.
21. McGregor ED Dunn MJ. Proteomics of heart disease. Hum Mol Genet 2003 12 R135 44.
22. Mann M Jensen ON. Proteomic analysis of post-translational modifications. Nat Biotechnol 2003 21 255 61.
23. Bland JL Lowenstein E. Halothane-induced decrease in experimental myocardial ischemia in the non-failing canine heart. Anesthesiology 1976 45 287 93.
24. Murry CE Jennings RB Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986 74 1124 36.
25. Bolli R. The late phase of preconditioning. Circ Res 2000 87 972 83.
26. Zaugg M Lucchinetti E Uecker M Pasch T Schaub MC. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth 2003 91 551 65.
27. Tonkovic-Capin M Gross GJ Bosnjak ZJ Tweddell JS Fitzpatrick CM Baker JE. Delayed cardioprotection by isoflurane. role of K (ATP) channels. Am J Physiol Heart Circ Physiol 2002 283 H61 8.
28. Shi Y Hutchins WC Su J Siker D Hogg N Pritchard KA Jr. et al. Delayed cardioprotection with isoflurane. role of reactive oxygen and nitrogen. Am J Physiol Heart Circ Physiol 2005 288 H175 84.
29. Takano H Manchikalapudi S Tang XL Qiu Y Rizvi A Jadoon AK et al. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation 1998 98 441 9.
30. Baxter GF Goma FM Yellon DM. Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium. Basic Res Cardiol 1997 92 159 67.
31. Finegan BA Lopaschuk GD Gandhi M Clanachan AS. Ischemic preconditioning inhibits glycolysis and proton production in isolated working rat hearts. Am J Physiol Heart Circ Physiol 1995 269 H1767 75.
32. Tanaka K Kehl F Gu W Krolikowski JG Pagel PS Warltier DC et al. Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol 2002 282 H2018 23.
33. Tracey WR Treadway JL Magee WP Sutt JC McPherson RK Levy CB et al. Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor. Am J Physiol Heart Circ Physiol 2004 286 H1177 84.
34. Mullenheim JE Ebel D Frassdorf J Preckel B Thamer V Schlack W. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology 2002 96 934 40.
35. Novalija EV Varadarajan SG Camara AK An J Chen Q Riess ML et al. Anesthetic preconditioning: triggering role of reactive oxygen and nitrogen species in isolated hearts. Am J Physiol Heart Circ Physiol 2002 283 H44 52.
36. Riess MK Camara AK McCormick J Jiang MT Rhodes SS Stowe DF. Anesthetic preconditioning: the role of free radicals in sevoflurane-induced attenuation of mitochondrial electron transport in Guinea pig isolated hearts. Anesth Analg 2005 100 46 53.
37. Ludwig LT Tanaka K Eells JT Weihrauch D Pagel PS Kersten JR et al. Preconditioning by isoflurane is mediated by reactive oxygen species generated from mitochondrial electron transport chain complex III. Anesth Analg 2004 99 1308 15.
38. Lesnefsky E Chen Q Moghaddas S Hassan MO Tandler B Hoppel CL. Blockade of electron transport during ischemia protects cardiac mitochondria. J Biol Chem 2004 279 47961 7.
39. Riess M Camara AK Chen Q Novalija E Rhodes SS Stowe DF. Altered NADH and improved function by anesthetic and ischemic preconditioning in guinea pig intact hearts. Am J Physiol Heart Circ Physiol 2002 283 H53 60.
40. Skulachev V. NAD (P) (+) decomposition and antioxidant defense of the cell. FEBS Lett 2001 492 1 3.
41. Morgan EB Boyle EM Yun W Griscavage-Ennis JM Farr AL Canty TG et al. An essential role for NF-kappaB in the cardioadaptive response to ischemia. Ann Thorac Surg 1999 68 377 82.
42. Xuan YT Tang XL Banerjee S Takano H Li RC Han H et al. Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res 1999 84 1095 109.
43. Feng XG Guo Z Nourbakhsh M Hauser H Ganster R Shao L et al. Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS gene. Proc Natl Acad Sci USA 2002 99 14212 7.
44. Laclau MB Boudina S Thambo JB Tariosse L Gouverneur G Bonoron-Adele S et al. Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase. J Mol Cell Cardiol 2001 33 947 56.
45. Yeung KJ Janosch P McFerran B Rose DW Mischak H Sedivy JM et al. Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol 2000 20 3079 85.
46. da Silva RG Gramp T Pasch T Schaub MC Zaugg M. Differential activation of mitogen-activated protein kinases in ischemic and anesthetic preconditioning. Anesthesiology 2004 100 59 69.
47. Maulik NW Watanab M Zu YL Huang CK Cordis GA Schley JA et al. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 1996 396 233 7.
48. Yeung KR Rose DW Dhillon AS Yaros D Gustafsson M Chatterjee D et al. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 2001 21 7207 17.
49. Shinmura KB Bolli R Liu SQ Tang XL Kodani E Xuan YT et al. Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ Res 2002 91 240 6.
50. Xanthoudakis SN Nicholson DW. Heat-shock proteins as death determinants. Nat Cell Biol 2000 2 E163 5.
51. Jayakumar JS Suzuki K Sammut IA Smolenski RT Khan M Latif N et al. Heat shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia-reperfusion injury. Circulation 2001 104 I303 7.
52. Garcia C Julier K Bestmann L Zollinger A von Segesser LK Pasch T et al. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth 2005 94 159 65.
53. Kehl F Pagel PS Krolikowski JG Gu W Toller W Warltier DC et al. Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo. Anesth Analg 2002 95 1162 8.
54. Kato RF Foex P. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Can J Anaesth 2002 49 777 91.
55. Preckel BS Schlack W Comfere T Obal D Barthel H Thamer V. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998 81 905 12.